ESPN or Oprah? Why patient waiting areas matter. Read post.

 

Editor's picks

Our reads for the weekend

April 13, 2012

The Daily Briefing editorial team highlights several studies and articles that got us talking this week.

Health and science experts from around the country gathered in Washington, D.C., this week for TEDMED. Couldn't make it? NPR's Scott Hensley explains what you're missing. More.

Does your sibling’s stroke mean you’re next? A study in Circulation: Cardiovascular Genetics finds that people whose brother or sister have suffered a stroke are up to 64% more likely to suffer one of their own. More.

Billionaires for the Cure: A Forbes slideshow spotlights medical research's biggest donors. More.

Can a public health expert change the World Bank? In the New York Times this week, Dartmouth College President Jim Yong Kim outlined his vision for the bank, which President Obama has tapped him to lead. More.

You-are-feeling-very-healthy... The Wall Street Journal's Melinda Beck explains how hypnosis may boost medical outcomes. More.

Writing for CNN, one of the physicians preparing the DSM-5 explains the reasoning behind controversial changes to the autism diagnosis. More.

Time's "Healthland" this month spotlighted a Cedars-Sinai Medical Center workshop for Jewish parents-to-be that covers a wide range of Jewish customs involved in childrearing. “Many people are not connected to their faith community so they don’t have clergy they call their own,” says the hospital's senior rabbi. “With parenthood approaching, they’re thinking about values and what’s meaningful to them. We realized we have the opportunity to be a bridge.” More.

A study in Cancer suggests a link between dental X-rays and increase brain cancer risks. More.

Sales of two of the most popular prescription painkillers in the United States—oxycodone and hydrocodone—have soared over the last decade, contributing to a surge in overdoses and armed pharmacy robberies. The New York Times examines ways to control the trend. More.

When Gardasil launched in 2007, U.S. sales immediately hit $1.5 billion. By 2010, that number dropped to nearly $1 billion. Writing in Forbes, Matthew Herper explains how the United States lost faith in the HPV vaccine—and how it's effecting the rest of the world. More.

Comment Now

You must be logged in to comment

  • Manage your events
  • View your saved items
  • Manage your subscriptions
  • Update personal information
  • Invite a colleague